Challenges of glycosylation analysis and control: an integrated approach to producing optimal and consistent therapeutic drugs.

Glycosylation of therapeutic proteins has a profound impact on their safety and efficacy. Many factors shape the glycosylation of biotherapeutics, ranging from expression systems and cell culture processes to downstream purification strategies. Various analytical technologies have been developed to address questions concerning different aspects of glycosylation. Informatics tools are also crucial for a systematic understanding of the glycosylation processes. Hence, an integrated approach is required to harness glycosylation for the production of optimal and consistent glycoprotein-based therapeutic drugs. Here, we review the latest developments and challenges in glycosylation analysis and control in the context of bioprocessing monoclonal antibodies.

[1]  Y. Misumi,et al.  Construction and expression of two mouse-human chimeric antibodies with high specificity and affinity for carcinoembryonic antigen. , 1993, Hybridoma.

[2]  Andrew G McDonald,et al.  Databases and tools in glycobiology. , 2012, Methods in molecular biology.

[3]  Kiyoko F. Aoki-Kinoshita,et al.  KEGG as a glycome informatics resource. , 2006, Glycobiology.

[4]  Zhongqi Zhang,et al.  Mass spectrometry for structural characterization of therapeutic antibodies. , 2009, Mass spectrometry reviews.

[5]  M. J. Chalmers,et al.  Combined electron capture and infrared multiphoton dissociation for multistage MS/MS in a Fourier transform ion cyclotron resonance mass spectrometer. , 2003, Analytical chemistry.

[6]  C. Costello,et al.  Detailed glycan structural characterization by electronic excitation dissociation. , 2013, Analytical chemistry.

[7]  Anurag S Rathore,et al.  Design of experiments applications in bioprocessing: Concepts and approach , 2014, Biotechnology progress.

[8]  E. Go,et al.  GlycoPep DB: a tool for glycopeptide analysis using a "Smart Search". , 2007, Analytical chemistry.

[9]  A. Manning,et al.  Controlled tetra-Fc sialylation of IVIg results in a drug candidate with consistent enhanced anti-inflammatory activity , 2015, Proceedings of the National Academy of Sciences.

[10]  R. Kunert,et al.  A close look at human IgG sialylation and subclass distribution after lectin fractionation , 2009, Proteomics.

[11]  G. Pastores.  Recombinant Glucocerebrosidase (Imiglucerase) as a Therapy for Gaucher Disease , 2010, BioDrugs.

[12]  S. Fujimoto,et al.  Glycosylation and Placental Transport of Immunoglobulin G , 1996 .

[13]  E. Read,et al.  Industry and regulatory experience of the glycosylation of monoclonal antibodies , 2011, Biotechnology and applied biochemistry.

[14]  Patrick Hossler,et al.  Protein glycosylation control in mammalian cell culture: past precedents and contemporary prospects. , 2012, Advances in biochemical engineering/biotechnology.

[15]  Matthew J. Moscou,et al.  A Simple Cipher Governs DNA Recognition by TAL Effectors , 2009, Science.

[16]  P. Rougé,et al.  Structural basis for the unusual carbohydrate-binding specificity of jacalin towards galactose and mannose. , 2002, The Biochemical journal.

[17]  Radoslav Goldman,et al.  Exploring site-specific N-glycosylation microheterogeneity of haptoglobin using glycopeptide CID tandem mass spectra and glycan database search. , 2013, Journal of proteome research.

[18]  Stefan Kol,et al.  One-step generation of triple knockout CHO cell lines using CRISPR/Cas9 and fluorescent enrichment. , 2015, Biotechnology journal.

[19]  Daniel F. Voytas,et al.  Zinc Finger Targeter (ZiFiT): an engineered zinc finger/target site design tool , 2007, Nucleic Acids Res..

[20]  J. Ravetch,et al.  Type I and type II Fc receptors regulate innate and adaptive immunity , 2014, Nature Immunology.

[21]  P. Cresswell,et al.  Essential glycan-dependent interactions optimize MHC class I peptide loading , 2011, Proceedings of the National Academy of Sciences.

[22]  D J Segal,et al.  Insights into the molecular recognition of the 5'-GNN-3' family of DNA sequences by zinc finger domains. , 2000, Journal of molecular biology.

[23]  Martin Schiestl,et al.  Acceptable changes in quality attributes of glycosylated biopharmaceuticals , 2011, Nature Biotechnology.

[24]  I. Goldstein,et al.  Characterization of the carbohydrate binding specificity of the leukoagglutinating lectin from Maackia amurensis. Comparison with other sialic acid-specific lectins. , 1991, The Journal of biological chemistry.

[25]  René Ranzinger,et al.  “Glyco‐peakfinder” – de novo composition analysis of glycoconjugates , 2007, Proteomics.

[26]  André M Deelder,et al.  Glycoproteomics based on tandem mass spectrometry of glycopeptides. , 2007, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[27]  R. Cummings,et al.  The immobilized leukoagglutinin from the seeds of Maackia amurensis binds with high affinity to complex-type Asn-linked oligosaccharides containing terminal sialic acid-linked alpha-2,3 to penultimate galactose residues. , 1988, The Journal of biological chemistry.

[28]  A. Varki,et al.  Production platforms for biotherapeutic glycoproteins. Occurrence, impact, and challenges of non-human sialylation , 2012, Biotechnology & genetic engineering reviews.

[29]  D. James,et al.  Control of Recombinant Monoclonal Antibody Effector Functions by Fc N‐Glycan Remodeling in Vitro , 2005, Biotechnology progress.

[30]  S. Kaveri,et al.  Intravenous Immunoglobulin Expands Regulatory T Cells in Autoimmune Rheumatic Disease , 2012, The Journal of Rheumatology.

[31]  Kiyoko F Aoki-Kinoshita.  Analyzing glycan structure synthesis with the Glycan Pathway Predictor (GPP) Tool. , 2015, Methods in molecular biology.

[32]  Niclas G Karlsson,et al.  Development of a mass fingerprinting tool for automated interpretation of oligosaccharide fragmentation data , 2004, Proteomics.

[33]  P. Rudd,et al.  Separation of 2-aminobenzamide labeled glycans using hydrophilic interaction chromatography columns packed with 1.7 microm sorbent. , 2010, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[34]  Steven C L Ho,et al.  Generation of monoclonal antibody-producing mammalian cell lines , 2013 .

[35]  A. Zuercher,et al.  Therapeutic Effect of IVIG on Inflammatory Arthritis in Mice Is Dependent on the Fc Portion and Independent of Sialylation or Basophils , 2014, The Journal of Immunology.

[36]  M. Tajiri,et al.  Hydrophilic affinity isolation and MALDI multiple-stage tandem mass spectrometry of glycopeptides for glycoproteomics. , 2004, Analytical chemistry.

[37]  Saurabh Aggarwal,et al.  What's fueling the biotech engine—2012 to 2013 , 2014, Nature Biotechnology.

[38]  K. Shitara,et al.  The Absence of Fucose but Not the Presence of Galactose or Bisecting N-Acetylglucosamine of Human IgG1 Complex-type Oligosaccharides Shows the Critical Role of Enhancing Antibody-dependent Cellular Cytotoxicity* , 2003, The Journal of Biological Chemistry.

[39]  Alain Van Dorsselaer,et al.  Characterization by liquid chromatography combined with mass spectrometry of monoclonal anti-IGF-1 receptor antibodies produced in CHO and NS0 cells. , 2004, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[40]  P. Stanley,et al.  Lectin-resistant CHO glycosylation mutants. , 2006, Methods in enzymology.

[41]  M. Betenbaugh,et al.  A mathematical model of N-linked glycosylation. , 2005, Biotechnology and bioengineering.

[42]  Joseph Zaia,et al.  Mass spectrometry and the emerging field of glycomics. , 2008, Chemistry & biology.

[43]  GUIDELINE ON SIMILAR BIOLOGICAL MEDICINAL PRODUCTS CONTAINING BIOTECHNOLOGY-DERIVED PROTEINS AS ACTIVE SUBSTANCE: NON-CLINICAL AND CLINICAL ISSUES , 2011 .

[44]  Stephen P. Young,et al.  Role of Oligosaccharide Residues of IgG1-Fc in FcγRIIb Binding* , 2001, The Journal of Biological Chemistry.

[45]  Y. Yu,et al.  Rapid Preparation of Released N-Glycans for HILIC Analysis Using a Labeling Reagent that Facilitates Sensitive Fluorescence and ESI-MS Detection. , 2015, Analytical chemistry.

[46]  B. G. Davis,et al.  Glycoprotein synthesis: an update. , 2009, Chemical reviews.

[47]  Denise M O'Hara,et al.  Engineering a Monomeric Fc Domain Modality by N-Glycosylation for the Half-life Extension of Biotherapeutics , 2013, The Journal of Biological Chemistry.

[48]  Cleo Kontoravdi,et al.  Applying quality by design to glycoprotein therapeutics: experimental and computational efforts of process control , 2013 .

[49]  T. Platts-Mills,et al.  Allergenicity of Carbohydrates and Their Role in Anaphylactic Events , 2010, Current allergy and asthma reports.

[50]  Neville E Sanjana,et al.  A transcription activator-like effector toolbox for genome engineering , 2012, Nature Protocols.

[51]  Yee Ying Tan,et al.  Using detonation nanodiamond for the specific capture of glycoproteins. , 2008, Analytical chemistry.

[52]  R. Huber,et al.  Structural analysis of human IgG-Fc glycoforms reveals a correlation between glycosylation and structural integrity. , 2003, Journal of molecular biology.

[53]  Catherine A. Hayes,et al.  UniCarb-DB: a database resource for glycomic discovery , 2011, Bioinform..

[54]  D. Burton,et al.  The C1q receptor site on immunoglobulin G , 1980, Nature.

[55]  M. Bardor,et al.  CHO glycosylation mutants as potential host cells to produce therapeutic proteins with enhanced efficacy. , 2013, Advances in biochemical engineering/biotechnology.

[56]  J. Stadlmann,et al.  Analytical and Functional Aspects of Antibody Sialylation , 2010, Journal of Clinical Immunology.

[57]  William S York,et al.  Regulation of Glycan Structures in Animal Tissues , 2008, Journal of Biological Chemistry.

[58]  A. Sinclair.  Erythropoiesis stimulating agents: approaches to modulate activity , 2013, Biologics : targets & therapy.

[59]  E. Padlan,et al.  Anatomy of the antibody molecule. , 1994, Molecular immunology.

[60]  E. Cantin,et al.  Fc-sialylated IgGs in intravenous immunoglobulins are not responsible for induction of regulatory T cells. , 2014, The Journal of allergy and clinical immunology.

[61]  Guonan Chen,et al.  Synthesis of magnetic nanoparticles with immobilized aminophenylboronic acid for selective capture of glycoproteins , 2011 .

[62]  Jeanine J. Houwing-Duistermaat,et al.  Loci Associated with N-Glycosylation of Human Immunoglobulin G Show Pleiotropy with Autoimmune Diseases and Haematological Cancers , 2013, PLoS genetics.

[63]  Li Wang,et al.  Erratum: Efficient design and assembly of custom TALEN and other TAL effector-based constructs for DNA targeting (Nucleic Acids Research (2011) 39 (e82) DOI: 10.1093/nar/gkr218) , 2011 .

[64]  Alain Van Dorsselaer,et al.  Characterization of therapeutic antibodies and related products. , 2013, Analytical chemistry.

[65]  E. Kabat,et al.  Antibody variable region glycosylation: position effects on antigen binding and carbohydrate structure. , 1991, The EMBO journal.

[66]  Zhikai Zhu,et al.  GlycoPep Detector: a tool for assigning mass spectrometry data of N-linked glycopeptides on the basis of their electron transfer dissociation spectra. , 2013, Analytical chemistry.

[67]  H. Mellstedt.  European Perspective on Biosimilars. , 2017, Journal of oncology practice.

[68]  Le Cong,et al.  Multiplex Genome Engineering Using CRISPR/Cas Systems , 2013, Science.

[69]  Y. Shoenfeld,et al.  Intravenous Immunoglobulin Therapy Affects T Regulatory Cells by Increasing Their Suppressive Function , 2007, The Journal of Immunology.

[70]  John A. Miller,et al.  GlycoVault: A Bioinformatics Infrastructure for Glycan Pathway Visualization, Analysis and Modeling , 2008, Fifth International Conference on Information Technology: New Generations (itng 2008).

[71]  Wei-Shou Hu,et al.  GlycoVis: Visualizing glycan distribution in the protein N‐glycosylation pathway in mammalian cells , 2006, Biotechnology and bioengineering.

[72]  M. Wormald,et al.  At least two Fc Neu5Gc residues of monoclonal antibodies are required for binding to anti-Neu5Gc antibody , 2016, Scientific Reports.

[73]  P. Parren,et al.  Anti-galactose-α-1,3-galactose IgE from allergic patients does not bind α-galactosylated glycans on intact therapeutic antibody Fc domains , 2011, Nature Biotechnology.

[74]  R. Dwek,et al.  The use of protein A and concanavalin A to examine the possible role of the carbohydrate of IgG in the binding of Clq. , 1981, Molecular immunology.

[75]  N. Leymarie,et al.  Effective use of mass spectrometry for glycan and glycopeptide structural analysis. , 2012, Analytical chemistry.

[76]  R. Bayer,et al.  Recovery and purification process development for monoclonal antibody production , 2010, mAbs.

[77]  P. Gagnon.  Technology trends in antibody purification. , 2012, Journal of chromatography. A.

[78]  M. Crispin,et al.  Fragmentation of negative ions from N-linked carbohydrates: part 6. Glycans containing one N-acetylglucosamine in the core. , 2014, Rapid communications in mass spectrometry : RCM.

[79]  Brian Kelley,et al.  Industrialization of mAb production technology: The bioprocessing industry at a crossroads , 2009, mAbs.

[80]  A. Deelder,et al.  Protein glycosylation analyzed by normal-phase nano-liquid chromatography--mass spectrometry of glycopeptides. , 2005, Analytical chemistry.

[81]  F. Scheller,et al.  Label‐free detection of enhanced saccharide binding at pH 7.4 to nanoparticulate benzoboroxole based receptor units , 2011, Journal of molecular recognition : JMR.

[82]  T. Hamblin,et al.  Acquisition of potential N-glycosylation sites in the immunoglobulin variable region by somatic mutation is a distinctive feature of follicular lymphoma. , 2002, Blood.

[83]  M. Naiki,et al.  Antigen of "serum sickness" type of heterophile antibodies in human sera: indentification as gangliosides with N-glycolylneuraminic acid. , 1977, Biochemical and biophysical research communications.

[84]  E. Go,et al.  Simplification of mass spectral analysis of acidic glycopeptides using GlycoPep ID. , 2007, Analytical chemistry.

[85]  A. Soffientini,et al.  Evaluation of phenylboronate agarose for industrial-scale purification of erythropoietin from mammalian cell cultures. , 2003, Journal of biotechnology.

[86]  P. Solich,et al.  Advantages of application of UPLC in pharmaceutical analysis. , 2006, Talanta.

[87]  J C Stewart,et al.  Antinutritive effects of wheat-germ agglutinin and other N-acetylglucosamine-specific lectins , 1993, British Journal of Nutrition.

[88]  C. Case,et al.  Validated Zinc Finger Protein Designs for All 16 GNN DNA Triplet Targets* , 2002, The Journal of Biological Chemistry.

[89]  Z. Li,et al.  Optimal and consistent protein glycosylation in mammalian cell culture. , 2009, Glycobiology.

[90]  J. Shabanowitz,et al.  Peptide and protein sequence analysis by electron transfer dissociation mass spectrometry. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[91]  Yunchun Liu,et al.  A Wulff-type boronate for boronate affinity capture of cis-diol compounds at medium acidic pH condition. , 2011, Chemical communications.

[92]  K. Yasumoto,et al.  Accumulation enhancement of human monoclonal antibody HB4C5 to lung tumor xenografts by N-deglycosylation. , 1994, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[93]  R. Kelly,et al.  Enhanced sialylation of a human chimeric IgG1 variant produced in human and rodent cell lines. , 2016, Journal of immunological methods.

[94]  Robert J Linhardt,et al.  Negative electron transfer dissociation of glycosaminoglycans. , 2010, Analytical chemistry.

[95]  Kelley W. Moremen,et al.  Vertebrate protein glycosylation: diversity, synthesis and function , 2012, Nature Reviews Molecular Cell Biology.

[96]  Yuting Zhang,et al.  Benzoboroxole-functionalized magnetic core/shell microspheres for highly specific enrichment of glycoproteins under physiological conditions. , 2014, Small.

[97]  Jason C Rouse,et al.  Unit mass baseline resolution for an intact 148 kDa therapeutic monoclonal antibody by Fourier transform ion cyclotron resonance mass spectrometry. , 2011, Analytical chemistry.

[98]  William S Hancock,et al.  Using lectins to harvest the plasma/serum glycoproteome , 2012, Electrophoresis.

[99]  Jens Boch,et al.  Breaking the Code of DNA Binding Specificity of TAL-Type III Effectors , 2009, Science.

[100]  J. Leary,et al.  STAT: a saccharide topology analysis tool used in combination with tandem mass spectrometry. , 2000, Analytical chemistry.

[101]  Y. Mechref,et al.  Characterizing protein glycosylation sites through higher-energy C-trap dissociation. , 2010, Rapid communications in mass spectrometry : RCM.

[102]  J. Yoo,et al.  Analytical platform for glycomic characterization of recombinant erythropoietin biotherapeutics and biosimilars by MS. , 2013, Bioanalysis.

[103]  Jakob Bunkenborg,et al.  A new strategy for identification of N-glycosylated proteins and unambiguous assignment of their glycosylation sites using HILIC enrichment and partial deglycosylation. , 2004, Journal of proteome research.

[104]  J E Bailey,et al.  A mathematical model of N-linked glycoform biosynthesis. , 1997, Biotechnology and bioengineering.

[105]  R. Dwek,et al.  "Internal residue loss": rearrangements occurring during the fragmentation of carbohydrates derivatized at the reducing terminus. , 2002, Analytical chemistry.

[106]  George M. Church,et al.  CHOPCHOP: a CRISPR/Cas9 and TALEN web tool for genome editing , 2014, Nucleic Acids Res..

[107]  Tilman Schlothauer,et al.  In Vitro Glycoengineering of IgG1 and Its Effect on Fc Receptor Binding and ADCC Activity , 2015, PloS one.

[108]  R. Salter,et al.  Binding and uptake of agalactosyl IgG by mannose receptor on macrophages and dendritic cells. , 1999, Journal of immunology.

[109]  R. Orlando,et al.  Tools for glycoproteomic analysis: size exclusion chromatography facilitates identification of tryptic glycopeptides with N-linked glycosylation sites. , 2006, Journal of proteome research.

[110]  Kiyoko F. Aoki-Kinoshita,et al.  From genomics to chemical genomics: new developments in KEGG , 2005, Nucleic Acids Res..

[111]  James Paulson,et al.  Automatic annotation of matrix‐assisted laser desorption/ionization N‐glycan spectra , 2005, Proteomics.

[112]  M Goodall,et al.  The influence of glycosylation on the thermal stability and effector function expression of human IgG1-Fc: properties of a series of truncated glycoforms. , 2000, Molecular immunology.

[113]  L. Presta,et al.  Lack of Fucose on Human IgG1 N-Linked Oligosaccharide Improves Binding to Human FcγRIII and Antibody-dependent Cellular Toxicity* , 2002, The Journal of Biological Chemistry.

[114]  K. Killeen,et al.  Characterization of IgG N-glycans employing a microfluidic chip that integrates glycan cleavage, sample purification, LC separation, and MS detection. , 2009, Analytical chemistry.

[115]  Jia-Ming Yang,et al.  Investigation of the correlation between charge and glycosylation of IgG1 variants by liquid chromatography-mass spectrometry. , 2014, Analytical biochemistry.

[116]  Niki S. C. Wong,et al.  A study of monoclonal antibody‐producing CHO cell lines: What makes a stable high producer? , 2009, Biotechnology and bioengineering.

[117]  Pauline M Rudd,et al.  The impact of glycosylation on the biological function and structure of human immunoglobulins. , 2007, Annual review of immunology.

[118]  Rui Nian,et al.  Chromatin-mediated depression of fractionation performance on electronegative multimodal chromatography media, its prevention, and ramifications for purification of immunoglobulin G. , 2014, Journal of chromatography. A.

[119]  Wei-Shou Hu,et al.  Systems Analysis of N-Glycan Processing in Mammalian Cells , 2007, PloS one.

[120]  Christopher R Lowe,et al.  Affinity ligands for glycoprotein purification based on the multi-component Ugi reaction. , 2014, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[121]  Kelvin H. Lee,et al.  The genomic sequence of the Chinese hamster ovary (CHO)-K1 cell line , 2011, Nature Biotechnology.

[122]  A. J. Parodi,et al.  Protein glucosylation and its role in protein folding. , 2000, Annual review of biochemistry.

[123]  Haixu Tang,et al.  Automated interpretation of MS/MS spectra of oligosaccharides , 2005, ISMB.

[124]  S. Nishimura,et al.  Separation of isomeric 2-aminopyridine derivatized N-glycans and N-glycopeptides of human serum immunoglobulin G by using a zwitterionic type of hydrophilic-interaction chromatography. , 2006, Journal of chromatography. A.

[125]  C. Scarff,et al.  Travelling wave ion mobility and negative ion fragmentation for the structural determination of N‐linked glycans , 2013, Electrophoresis.

[126]  André M Deelder,et al.  Protein glycosylation analysis by liquid chromatography-mass spectrometry. , 2005, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[127]  J. Berlin,et al.  High incidence of cetuximab-related infusion reactions in Tennessee and North Carolina and the association with atopic history. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[128]  R. Dwek,et al.  Human Follicular Lymphoma Cells Contain Oligomannose Glycans in the Antigen-binding Site of the B-cell Receptor* , 2007, Journal of Biological Chemistry.

[129]  S. Fujii,et al.  Glycosylation at the Fab portion of myeloma immunoglobulin G and increased fucosylated biantennary sugar chains: structural analysis by high-performance liquid chromatography and antibody-lectin enzyme immunoassay using Lens culinaris agglutinin. , 1991, Cancer research.

[130]  S. Misbah,et al.  Cetuximab-induced anaphylaxis and IgE specific for galactose-alpha-1,3-galactose. , 2008, The New England journal of medicine.

[131]  P. Bondarenko,et al.  High-mannose glycans on the Fc region of therapeutic IgG antibodies increase serum clearance in humans. , 2011, Glycobiology.

[132]  Feng Li,et al.  Cell culture processes for monoclonal antibody production , 2010, mAbs.

[133]  Elo Leung,et al.  A TALE nuclease architecture for efficient genome editing , 2011, Nature Biotechnology.

[134]  T. Platts-Mills,et al.  The relevance of tick bites to the production of IgE antibodies to the mammalian oligosaccharide galactose-α-1,3-galactose. , 2011, The Journal of allergy and clinical immunology.

[135]  Peiqing Zhang,et al.  RCA-I-resistant CHO mutant cells have dysfunctional GnT I and expression of normal GnT I in these mutants enhances sialylation of recombinant erythropoietin. , 2010, Metabolic engineering.

[136]  H. Wandall,et al.  Precision genome editing: a small revolution for glycobiology. , 2014, Glycobiology.

[137]  Pauline M Rudd,et al.  Automated, high-throughput IgG-antibody glycoprofiling platform. , 2013, Analytical chemistry.

[138]  Michael J Gramer,et al.  Product quality considerations for mammalian cell culture process development and manufacturing. , 2014, Advances in biochemical engineering/biotechnology.

[139]  R. Dwek,et al.  Glycosylation and the immune system. , 2001, Science.

[140]  H. Deicher.  Über die Erzeugung heterospezifischer Hämagglutinine durch Injektion artfremden Serums , 1926, Zeitschrift für Hygiene und Infektionskrankheiten.

[141]  H. Ju,et al.  Facile synthesis of boronic acid-functionalized magnetic carbon nanotubes for highly specific enrichment of glycopeptides. , 2014, Nanoscale.

[142]  Anurag S Rathore,et al.  Roadmap for implementation of quality by design (QbD) for biotechnology products. , 2009, Trends in biotechnology.

[143]  Serge Rudaz,et al.  New trends in fast and high-resolution liquid chromatography: a critical comparison of existing approaches , 2010, Analytical and bioanalytical chemistry.

[144]  B. Garcia.  What does the future hold for top down mass spectrometry? , 2010, Journal of the American Society for Mass Spectrometry.

[145]  T. Hayakawa,et al.  Site-specific N-glycosylation analysis of human plasma ceruloplasmin using liquid chromatography with electrospray ionization tandem mass spectrometry. , 2006, Analytical biochemistry.

[146]  David Hua,et al.  GlycoPep grader: a web-based utility for assigning the composition of N-linked glycopeptides. , 2012, Analytical chemistry.

[147]  E. Deverson,et al.  Primary structure of kappa light chain from a human myeloma protein. , 1974, European journal of biochemistry.

[148]  M. Daëron.  Fc Receptors as Adaptive Immunoreceptors , 2014, Current topics in microbiology and immunology.

[149]  Xiangshan Zhou,et al.  Highly sialylated recombinant human erythropoietin production in large‐scale perfusion bioreactor utilizing CHO‐gmt4 (JW152) with restored GnT I function , 2014, Biotechnology journal.

[150]  Gary J Lye,et al.  Microwell engineering characterization for mammalian cell culture process development , 2010, Biotechnology and bioengineering.

[151]  Fleur S. van de Bovenkamp,et al.  Inhibition of FcγR-mediated phagocytosis by IVIg is independent of IgG-Fc sialylation and FcγRIIb in human macrophages. , 2014, Blood.

[152]  C. Kontoravdi,et al.  A dynamic mathematical model for monoclonal antibody N‐linked glycosylation and nucleotide sugar donor transport within a maturing Golgi apparatus , 2011, Biotechnology progress.

[153]  Hiroaki Nakagawa,et al.  High-throughput protein glycomics: combined use of chemoselective glycoblotting and MALDI-TOF/TOF mass spectrometry. , 2004, Angewandte Chemie.

[154]  David Goldberg,et al.  Automated N-glycopeptide identification using a combination of single- and tandem-MS. , 2007, Journal of proteome research.

[155]  M. Wormald,et al.  Glycosylation and Fc receptors. , 2014, Current topics in microbiology and immunology.

[156]  A G Marshall,et al.  Electron capture dissociation and infrared multiphoton dissociation MS/MS of an N-glycosylated tryptic peptic to yield complementary sequence information. , 2001, Analytical chemistry.

[157]  E. Kabat,et al.  Sequences of proteins of immunological interest , 1991 .

[158]  English Only,et al.  GUIDELINES ON EVALUATION OF SIMILAR BIOTHERAPEUTIC PRODUCTS (SBPs) , 2009 .

[159]  Andrew J Racher,et al.  Functional heterogeneity and heritability in CHO cell populations , 2013, Biotechnology and bioengineering.

[160]  Ruedi Aebersold,et al.  Identification and quantification of N-linked glycoproteins using hydrazide chemistry, stable isotope labeling and mass spectrometry , 2003, Nature Biotechnology.

[161]  Pauline M Rudd,et al.  A systematic approach to protein glycosylation analysis: a path through the maze. , 2010, Nature chemical biology.

[162]  Claus-W von der Lieth,et al.  GLYCO‐FRAGMENT: A web tool to support the interpretation of mass spectra of complex carbohydrates , 2003, Proteomics.

[163]  Claus-Wilhelm von der Lieth,et al.  GlycoFragment and GlycoSearchMS: web tools to support the interpretation of mass spectra of complex carbohydrates , 2004, Nucleic Acids Res..

[164]  E. Toone,et al.  Specificity of C-glycoside complexation by mannose/glucose specific lectins. , 1996, Biochemistry.

[165]  L. R. Ruhaak,et al.  Glycan labeling strategies and their use in identification and quantification , 2010, Analytical and bioanalytical chemistry.

[166]  C. Klein,et al.  Increasing the efficacy of CD20 antibody therapy through the engineering of a new type II anti-CD20 antibody with enhanced direct and immune effector cell-mediated B-cell cytotoxicity. , 2010, Blood.

[167]  T. Platts-Mills,et al.  Delayed anaphylaxis, angioedema, or urticaria after consumption of red meat in patients with IgE antibodies specific for galactose-alpha-1,3-galactose. , 2009, The Journal of allergy and clinical immunology.

[168]  T. Stehle,et al.  The sweet spot: defining virus–sialic acid interactions , 2014, Nature Reviews Microbiology.

[169]  Robert M. Anthony,et al.  Recapitulation of IVIG Anti-Inflammatory Activity with a Recombinant IgG Fc , 2008, Science.

[170]  Erin L. Doyle,et al.  Efficient design and assembly of custom TALEN and other TAL effector-based constructs for DNA targeting , 2011, Nucleic acids research.

[171]  Ana M Azevedo,et al.  Phenylboronic acid as a multi-modal ligand for the capture of monoclonal antibodies: development and optimization of a washing step. , 2014, Journal of chromatography. A.

[172]  P. Bondarenko,et al.  Mass measurement and top-down HPLC/MS analysis of intact monoclonal antibodies on a hybrid linear quadrupole ion trap-orbitrap mass spectrometer , 2009, Journal of the American Society for Mass Spectrometry.

[173]  C. Goodnow,et al.  Redemption of autoantibodies on anergic B cells by variable-region glycosylation and mutation away from self-reactivity , 2014, Proceedings of the National Academy of Sciences.

[174]  Jeffry D Sander,et al.  FLAsH assembly of TALeNs for high-throughput genome editing , 2022 .

[175]  Hongwei Xie,et al.  Rapid comparison of a candidate biosimilar to an innovator monoclonal antibody with advanced liquid chromatography and mass spectrometry technologies , 2010, mAbs.

[176]  P. Gagnon,et al.  High productivity purification of immunoglobulin G monoclonal antibodies on starch-coated magnetic nanoparticles by steric exclusion of polyethylene glycol. , 2014, Journal of chromatography. A.

[177]  D J Segal,et al.  Toward controlling gene expression at will: selection and design of zinc finger domains recognizing each of the 5'-GNN-3' DNA target sequences. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[178]  M. Naiki,et al.  Immunogenicity of N-glycolylneuraminic acid-containing carbohydrate chains of recombinant human erythropoietin expressed in Chinese hamster ovary cells. , 1995, Journal of biochemistry.

[179]  Alessio Ceroni,et al.  The GlycanBuilder: a fast, intuitive and flexible software tool for building and displaying glycan structures , 2007, Source Code for Biology and Medicine.

[180]  B. Pirofsky,et al.  "Foreign serum" heterophile antibodies in patients receiving antithymocyte antisera. , 1973, Blood.

[181]  Peiqing Zhang,et al.  The Golgi CMP-sialic acid transporter: A new CHO mutant provides functional insights. , 2008, Glycobiology.

[182]  Pengyuan Yang,et al.  Facile synthesis of aminophenylboronic acid-functionalized magnetic nanoparticles for selective separation of glycopeptides and glycoproteins. , 2008, Chemical communications.

[183]  D. Ecker,et al.  The therapeutic monoclonal antibody market , 2015, mAbs.

[184]  Philip M. Jedrzejewski,et al.  Towards Controlling the Glycoform: A Model Framework Linking Extracellular Metabolites to Antibody Glycosylation , 2014, International journal of molecular sciences.

[185]  L. James,et al.  1.9 A structure of the therapeutic antibody CAMPATH-1H fab in complex with a synthetic peptide antigen. , 1999, Journal of molecular biology.

[186]  Pauline M Rudd,et al.  An automated robotic platform for rapid profiling oligosaccharide analysis of monoclonal antibodies directly from cell culture. , 2013, Analytical biochemistry.

[187]  David A. Scott,et al.  Genome-wide binding of the CRISPR endonuclease Cas9 in mammalian cells , 2014, Nature Biotechnology.

[188]  A. Deelder,et al.  High-throughput work flow for IgG Fc-glycosylation analysis of biotechnological samples. , 2013, Analytical biochemistry.

[189]  Alois Jungbauer,et al.  Protein Chromatography: Process Development and Scale-Up , 2010 .

[190]  Z. Shriver,et al.  Chinese hamster ovary cells can produce galactose-α-1,3-galactose antigens on proteins , 2010, Nature Biotechnology.

[191]  Patrick Mayeux,et al.  Pure red-cell aplasia and antierythropoietin antibodies in patients treated with recombinant erythropoietin. , 2002, The New England journal of medicine.

[192]  M Angela Taipa,et al.  Antibodies and Genetically Engineered Related Molecules: Production and Purification , 2004, Biotechnology progress.

[193]  R Apweiler,et al.  On the frequency of protein glycosylation, as deduced from analysis of the SWISS-PROT database. , 1999, Biochimica et biophysica acta.

[194]  David Goldberg,et al.  Automatic determination of O-glycan structure from fragmentation spectra. , 2006, Journal of proteome research.

[195]  Daniel Kolarich,et al.  GlycoSpectrumScan: fishing glycopeptides from MS spectra of protease digests of human colostrum sIgA. , 2010, Journal of proteome research.

[196]  C. Scarff,et al.  Estimating collision cross sections of negatively charged N-glycans using traveling wave ion mobility-mass spectrometry. , 2014, Analytical Chemistry.

[197]  A. Varki,et al.  Implications of the presence of N-glycolylneuraminic acid in recombinant therapeutic glycoproteins , 2010, Nature Biotechnology.

[198]  E. Williams,et al.  Mechanism of charging and supercharging molecules in electrospray ionization. , 2003, Journal of the American Chemical Society.

[199]  M. Bardor,et al.  Control of IgG LC:HC ratio in stably transfected CHO cells and study of the impact on expression, aggregation, glycosylation and conformational stability. , 2013, Journal of biotechnology.

[200]  Mazhar Adli,et al.  Genome-wide analysis reveals characteristics of off-target sites bound by the Cas9 endonuclease , 2014, Nature Biotechnology.

[201]  Martin Frank,et al.  The role of informatics in glycobiology research with special emphasis on automatic interpretation of MS spectra. , 2006, Biochimica et biophysica acta.

[202]  Pauline M Rudd,et al.  Ultrahigh throughput, ultrafiltration-based n-glycomics platform for ultraperformance liquid chromatography (ULTRA(3)). , 2015, Analytical chemistry.

[203]  I. Rudan,et al.  High-throughput IgG Fc N-glycosylation profiling by mass spectrometry of glycopeptides. , 2013, Journal of proteome research.

[204]  Gary Walsh,et al.  Biopharmaceutical benchmarks 2014 , 2014, Nature Biotechnology.

[205]  J. Ravetch,et al.  Anti-Inflammatory Activity of Immunoglobulin G Resulting from Fc Sialylation , 2006, Science.

[206]  Naoyuki Taniguchi,et al.  Comparison of the methods for profiling glycoprotein glycans--HUPO Human Disease Glycomics/Proteome Initiative multi-institutional study. , 2007, Glycobiology.

[207]  R. Dwek,et al.  Variable region heavy chain glycosylation determines the anticoagulant activity of a factor VIII antibody , 2006, Journal of thrombosis and haemostasis : JTH.

[208]  Zhongqi Zhang,et al.  Characterization of variable regions of monoclonal antibodies by top-down mass spectrometry. , 2007, Analytical chemistry.

[209]  Wei Wang,et al.  Genomics Meets Glycomics—The First GWAS Study of Human N-Glycome Identifies HNF1α as a Master Regulator of Plasma Protein Fucosylation , 2010, PLoS genetics.

[210]  M. Bardor,et al.  IRES-mediated Tricistronic vectors for enhancing generation of high monoclonal antibody expressing CHO cell lines. , 2012, Journal of biotechnology.

[211]  Cleo Kontoravdi,et al.  Towards the implementation of quality by design to the production of therapeutic monoclonal antibodies with desired glycosylation patterns , 2010, Biotechnology progress.

[212]  A. Varki,et al.  Human uptake and incorporation of an immunogenic nonhuman dietary sialic acid , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[213]  A. Ghaemmaghami,et al.  Glycosylation of surface Ig creates a functional bridge between human follicular lymphoma and microenvironmental lectins , 2010, Proceedings of the National Academy of Sciences.

[214]  U. Reichl,et al.  Capture of cell culture-derived influenza virus by lectins: strain independent, but host cell dependent. , 2008, Journal of virological methods.

[215]  K. Håkansson,et al.  Infrared multiphoton dissociation and electron capture dissociation of high-mannose type glycopeptides. , 2006, Journal of proteome research.

[216]  Alex Eon-Duval,et al.  Quality attributes of recombinant therapeutic proteins: An assessment of impact on safety and efficacy as part of a quality by design development approach , 2012, Biotechnology progress.

[217]  Hervé Broly,et al.  Modulation of mAb quality attributes using microliter scale fed‐batch cultures , 2014, Biotechnology progress.

[218]  D. Ho,et al.  Strategic addition of an N-linked glycan to a monoclonal antibody improves its HIV-1-neutralizing activity , 2013, Nature Biotechnology.

[219]  Catherine A. Cooper,et al.  GlycoMod – A software tool for determining glycosylation compositions from mass spectrometric data , 2001, Proteomics.

[220]  F. J. Krambeck,et al.  A mathematical model to derive N-glycan structures and cellular enzyme activities from mass spectrometric data. , 2009, Glycobiology.

[221]  Hai Pan,et al.  A high‐throughput microchip‐based glycan screening assay for antibody cell culture samples , 2011, Electrophoresis.

[222]  Hisashi Narimatsu,et al.  Toolboxes for a standardised and systematic study of glycans , 2014, BMC Bioinformatics.

[223]  Pauline M Rudd,et al.  Multiplexed analytical glycomics: rapid and confident IgG N-glycan structural elucidation. , 2011, Journal of proteome research.

[224]  Peiqing Zhang,et al.  Identification of functional elements of the GDP-fucose transporter SLC35C1 using a novel Chinese hamster ovary mutant. , 2012, Glycobiology.

[225]  J. Ravetch,et al.  Anti-inflammatory activity of IVIG mediated through the inhibitory Fc receptor. , 2001, Science.

[226]  Y. Kao,et al.  On-line characterization of monoclonal antibody variants by liquid chromatography-mass spectrometry operating in a two-dimensional format. , 2011, Analytical biochemistry.

[227]  M. Schiestl.  A biosimilar industry view on the implementation of the WHO guidelines on evaluating similar biotherapeutic products. , 2011, Biologicals : journal of the International Association of Biological Standardization.

[228]  Louise Royle,et al.  Separation‐based Glycoprofiling Approaches using Fluorescent Labels , 2007, Proteomics.

[229]  GlycoPep Detector : A tool for assigning mass spectrometry data of N-linked glycopeptides based on their ETD spectra , 2013 .

[230]  Pauline M. Rudd,et al.  High Throughput Isolation and Glycosylation Analysis of IgG–Variability and Heritability of the IgG Glycome in Three Isolated Human Populations* , 2011, Molecular & Cellular Proteomics.

[231]  Pauline M. Rudd,et al.  GlycoProfileAssigner: automated structural assignment with error estimation for glycan LC data , 2015, Bioinform..

[232]  Shaleem I Jacob,et al.  Bespoke affinity ligands for the purification of therapeutic proteins , 2015 .

[233]  J. Ravetch,et al.  Intravenous gammaglobulin suppresses inflammation through a novel TH2 pathway , 2011, Nature.

[234]  B. Ma,et al.  GlycoMaster DB: software to assist the automated identification of N-linked glycopeptides by tandem mass spectrometry. , 2014, Journal of proteome research.

[235]  Matthew P Campbell,et al.  GlycoBase and autoGU: resources for interpreting HPLC-glycan data. , 2015, Methods in molecular biology.

[236]  S L Morrison,et al.  Glycosylation of a VH residue of a monoclonal antibody against alpha (1- ---6) dextran increases its affinity for antigen , 1988, The Journal of experimental medicine.

[237]  Armin Ruf,et al.  Unique carbohydrate–carbohydrate interactions are required for high affinity binding between FcγRIII and antibodies lacking core fucose , 2011, Proceedings of the National Academy of Sciences.

[238]  André M Deelder,et al.  Mass spectrometry of proton adducts of fucosylated N-glycans: fucose transfer between antennae gives rise to misleading fragments. , 2006, Rapid communications in mass spectrometry : RCM.

[239]  Quynh-Thu Le,et al.  Cetuximab-induced anaphylaxis and IgE specific for galactose-alpha-1,3-galactose. , 2008, The New England journal of medicine.

[240]  R. Dwek,et al.  Glycosylation changes of IgG associated with rheumatooid arthritis can activate complement via the mannose-binding protein , 1995, Nature Medicine.

[241]  M. Wuhrer,et al.  High-throughput glycosylation analysis of therapeutic immunoglobulin G by capillary gel electrophoresis using a DNA analyzer , 2014, mAbs.

[242]  S. Miescher,et al.  Intravenous IgG (IVIG) and subcutaneous IgG (SCIG) preparations have comparable inhibitory effect on T cell activation, which is not dependent on IgG sialylation, monocytes or B cells. , 2015, Clinical immunology.

[243]  Igor Rudan,et al.  Complex genetic regulation of protein glycosylation. , 2010, Molecular bioSystems.

[244]  Tom Vink,et al.  N‐linked glycosylation is an important parameter for optimal selection of cell lines producing biopharmaceutical human IgG , 2009, Biotechnology progress.

[245]  Y. Sugita,et al.  Confident identification of isomeric N-glycan structures by combined ion mobility mass spectrometry and hydrophilic interaction liquid chromatography. , 2012, Rapid communications in mass spectrometry : RCM.

[246]  Rachel Bareither,et al.  Automated disposable small scale reactor for high throughput bioprocess development: A proof of concept study , 2013, Biotechnology and bioengineering.

[247]  P. Rudd,et al.  5-AZA-2'-deoxycytidine induced demethylation influences N-glycosylation of secreted glycoproteins in ovarian cancer , 2011, Epigenetics.

[248]  R. Dwek,et al.  Site-specific glycosylation of human immunoglobulin G is altered in four rheumatoid arthritis patients. , 1996, The Biochemical journal.

[249]  T. Huizinga,et al.  Immunoglobulin 1 (IgG1) Fc‐glycosylation profiling of anti‐citrullinated peptide antibodies from human serum , 2009, Proteomics. Clinical applications.

[250]  Fred W. McLafferty,et al.  Top-down identification and characterization of biomolecules by mass spectrometry , 2008, Journal of the American Society for Mass Spectrometry.

[251]  Shin-Ichiro Nishimura,et al.  Glycoconjugate Data Bank:Structures—an annotated glycan structure database and N-glycan primary structure verification service , 2008, Nucleic Acids Res..

[252]  Jeffrey W. Smith,et al.  An intrinsic mechanism of secreted protein aging and turnover , 2015, Proceedings of the National Academy of Sciences of the United States of America.

[253]  James E. DiCarlo,et al.  RNA-Guided Human Genome Engineering via Cas9 , 2013, Science.

[254]  U. Reichl,et al.  Lectin-affinity chromatography for downstream processing of MDCK cell culture derived human influenza A viruses. , 2007, Vaccine.